Capstone Therapeutics

OverviewSuggest Edit

Capstone Therapeutics is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. Capstone holds an FDA Orphan drug designation for its lead molecule, AEM-28, for Homozygous Familial Hypercholesterolemia and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.
TypePublic
Founded1987
HQTempe, US
Websitecapstonethx.com

Locations

Capstone Therapeutics is headquartered in
Tempe, United States

Location Map

Latest Updates

Employees (est.) (Apr 2017)9

Capstone Therapeutics Office Locations

Capstone Therapeutics has an office in Tempe
Tempe, US (HQ)
1275 W Washington St
Show all (1)

Capstone Therapeutics Financials and Metrics

Capstone Therapeutics Revenue

USD

Net income (FY, 2018)

(380.0k)

Market capitalization (1-Oct-2018)

3.3m

Cash (31-Dec-2018)

1.3m
Capstone Therapeutics's current market capitalization is $3.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

General and administrative expense

1.2m1.5m1.8m543.0k641.0k554.0k

R&D expense

3.1m3.1m1.2m1.0m1.0m1.4m

Operating expense total

4.3m4.5m2.9m1.6m1.7m2.2m

Interest income

158.0k251.0k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

General and administrative expense

222.0k373.0k472.0k552.0k241.0k225.0k157.0k55.0k113.0k159.0k229.0k313.0k

R&D expense

1.2m865.0k350.0k283.0k175.0k157.0k220.0k446.0k267.0k386.0k301.0k623.0k

Operating expense total

1.4m1.2m822.0k835.0k416.0k382.0k377.0k501.0k380.0k545.0k530.0k1.2m

Interest income

3.0k4.0k122.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.2m1.0m698.0k1.3m1.3m

Current Assets

6.5m2.7m1.3m829.0k1.4m1.4m

Total Assets

7.3m3.4m1.8m1.2m1.6m1.5m

Accounts Payable

88.0k124.0k254.0k249.0k197.0k245.0k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

1.5m1.0m637.0k718.0k692.0k1.1m486.0k1.7m805.0k2.3m

Current Assets

4.5m3.4m2.2m1.5m997.0k943.0k769.0k1.2m568.0k1.8m881.0k2.3m

Total Assets

5.3m4.1m2.8m2.1m1.5m1.4m1.2m1.6m882.0k2.0m1.0m2.4m

Accounts Payable

112.0k225.0k185.0k211.0k132.0k173.0k402.0k325.0k324.0k157.0k203.0k244.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.1m)(4.2m)(2.8m)(663.0k)(1.8m)

Depreciation and Amortization

173.0k160.0k157.0k179.0k

Accounts Payable

(145.0k)36.0k130.0k(5.0k)(52.0k)

Cash From Operating Activities

(4.0m)(4.1m)(2.2m)(1.3m)(1.6m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Net Income

1.4m1.2m716.0k(1.5m)(1.9m)(379.0k)390.0k487.0k(387.0k)(1.2m)(587.0k)

Depreciation and Amortization

78.0k117.0k45.0k44.0k

Accounts Payable

112.0k225.0k185.0k87.0k8.0k(81.0k)402.0k325.0k75.0k(92.0k)6.0k

Cash From Operating Activities

(1.1m)(1.5m)(293.0k)(212.0k)(1.1m)(470.0k)
USDY, 2018

Financial Leverage

-1.2 x
Show all financial metrics

Capstone Therapeutics Online and Social Media Presence

Embed Graph

Capstone Therapeutics Frequently Asked Questions

  • When was Capstone Therapeutics founded?

    Capstone Therapeutics was founded in 1987.

  • How many employees does Capstone Therapeutics have?

    Capstone Therapeutics has 9 employees.

  • Who are Capstone Therapeutics competitors?

    Competitors of Capstone Therapeutics include Arrowhead Pharmaceuticals, Malin and TetraGenetics.

  • Where is Capstone Therapeutics headquarters?

    Capstone Therapeutics headquarters is located at 1275 W Washington St, Tempe.

  • Where are Capstone Therapeutics offices?

    Capstone Therapeutics has an office in Tempe.

  • How many offices does Capstone Therapeutics have?

    Capstone Therapeutics has 1 office.